StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a research note issued to investors on Wednesday. The firm set a “sell” rating on the basic materials company’s stock.
Arcadia Biosciences Price Performance
RKDA stock opened at $6.18 on Wednesday. The company’s 50-day moving average is $4.23 and its 200-day moving average is $3.37. The stock has a market capitalization of $8.44 million, a PE ratio of -1.44 and a beta of 1.19. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $10.31.
Arcadia Biosciences Company Profile
Read More
- Five stocks we like better than Arcadia Biosciences
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- High Dividend REITs: Are They an Ideal Way to Diversify?
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.